Inhibrx Biosciences, Inc. INBX
81.08 USD +8.92 (+12.36%)
At closeNov 4, 2026, 7:17 AM EST
80.70 -0.38 -0.47%
Pre-market · Nov 4, 7:17 AM ET
71.16 Day range 83.00
57.30 52-week range 155.29
- YTD
- +2.63%
- 1 year
- -0.44%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 266.67 +228.9% upside
Now 81.08
- Target (low)
- 230.00
- Target (mean)
- 266.67
- Target (high)
- 325.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy0
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.36 | -2.57 – -2.14 | -2.28 | -3.3% | 0 | 0.0% | 2 |
| Next quarter | -2.42 | -2.53 – -2.30 | -2.11 | -14.4% | 0 | 0.0% | 2 |
| Current year | -9.26 | -9.58 – -8.93 | -9.04 | -2.4% | 0 | -100.0% | 2 |
| Next year | -8.76 | -9.05 – -8.47 | -9.26 | +5.3% | 36.05M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 24, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 8, 2026 | Stifel | Initiated | — | Buy |
| Aug 22, 2025 | JMP Securities | Reiterated | Market Perform | Market Perform |
| May 15, 2025 | JMP Securities | Reiterated | Market Perform | Market Perform |
| Mar 18, 2025 | Citizens Capital Markets | Reiterated | Market Perform | Market Perform |
| Jan 22, 2025 | JMP Securities | Reiterated | Market Perform | Market Perform |
| Jul 23, 2024 | JMP Securities | Initiated | — | Market Perform |
| Jan 23, 2024 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Nov 20, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 23, 2023 | JMP Securities | Maintained | Outperform | Outperform |
| May 10, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 8, 2023 | JMP Securities | Maintained | — | Market Outperform |
| Mar 7, 2023 | Credit Suisse | Reiterated | — | Outperform |
| Nov 8, 2022 | Credit Suisse | Maintained | — | Outperform |
| Oct 5, 2022 | Evercore ISI Group | Maintained | — | Outperform |
| Aug 9, 2022 | Credit Suisse | Maintained | — | Outperform |
| Mar 16, 2022 | SMBC Nikko | Initiated | — | Outperform |
| Mar 2, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Nov 10, 2021 | Credit Suisse | Maintained | — | Outperform |
| Nov 2, 2021 | JMP Securities | Maintained | — | Market Outperform |
| Sep 21, 2021 | JMP Securities | Initiated | — | Market Outperform |
| Sep 14, 2020 | Jefferies | Initiated | — | Buy |
| Sep 14, 2020 | Evercore ISI Group | Initiated | — | Outperform |
| Sep 14, 2020 | Credit Suisse | Initiated | — | Outperform |